Events
Let’s Connect
The biosimilars community is dedicated to building a healthier future. Let’s come together to share ideas and resources to help increase patient access to biosimilars.
Experiences for Everyone
Biosimilar medicines have the power to help patients at a fraction of the cost of brand biologics. Advocates, scientists, patients and government officials must all join together to raise awareness of biosimilars and break down barriers to access. The Association for Accessible Medicines (AAM) and its Biosimilars Council are thrilled to host events that help promote biosimilars—and we are also proud to participate in events hosted by our partners and friends within the biosimilars community. Scroll to learn more and register for an upcoming event, and help biosimilar medicines reach their greatest potential.
October 21–23, 2024 | Rockville, MD
GRx+Biosims™ 2024 is the leading scientific, regulatory and policy event for the U.S. generics and biosimilars industry. This year, top officials and subject matter experts – including Dr. Jacqueline Corrigan-Curray, Dr. Iilun Murphy, Dr. Sarah Yim, and Dr. Elizabeth Miller from FDA – will share knowledge and best practices with attendees. Participants will also enjoy the opportunity to reflect on the remarkable career of Dr. Janet Woodcock, following her recent retirement from the FDA. The GRx+Biosims™ 2024 learning tracks will feature timely and interactive content relevant to technical, regulatory and policy professionals. Click below to register!
November 11–15, 2024 | Virtual
IGBA’s 5th annual Global Biosimilars Week (GBW) aims to raise awareness around the powerful and life-changing impact of biosimilar medicines. Through this social media campaign, we can help advance access to biosimilar medicines, across the globe. Patients, healthcare professionals, government officials and industry leaders are encouraged to share GBW resources using: #GlobalBiosimilarsWeek.
February 3–5, 2025 | Amelia Island, FL
Join the leaders and innovators who will shape the future of generics and biosimilars. AAM’s annual meeting promises an exciting experience fueled by in-depth knowledge sharing, real talk and fresh ideas. Attendees can expect to leave Access! 2025 with a renewed outlook on meeting the industry challenges of today and tomorrow. Click below to register for Access! today – then follow @accessiblemeds and @biosimilarscouncil on X for updates and info!